In the last trading session, 1,051,701 Twist Bioscience Corporation (NASDAQ:TWST) shares changed hands as the company’s beta touched 0. With the company’s per share price at $107.32 changed hands at -$8.27 or -0.07% during last session, the market valuation stood at $5.22 Billion. TWST’s last price was a discount, traded about -99.47% off its 52-week high of $214.07. The share price had its 52-week low at $25.72, which suggests the last value was 76.03% up since then. When we look at Twist Bioscience Corporation’s average trading volume, we note the 10-day average is 934.7 Million shares, with the 3-month average coming to 996.85 Million.
Analysts gave the Twist Bioscience Corporation (TWST) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.6. If we narrow down to specifics, the data shows that 1 out of 5 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 2 recommended TWST as a Hold, 1 felt it is a Buy and none rated the stock as Underweight. Twist Bioscience Corporation’s EPS for the current quarter is expected to be -$0.77.
Twist Bioscience Corporation (NASDAQ:TWST) trade information
Although TWST has turned red as seen at the end of in last trading. With action -7.15%, the performance over the past five days has been red. The jump to weekly highs of $135.1 on Tuesday, Mar 23 added 20.56% to the stock’s daily price. The company’s shares are showing year-to-date downside of -0.24%, with the 5-day performance at -0.21% in the red. However, in the 30-day time frame, Twist Bioscience Corporation (NASDAQ:TWST) is -0.22% down. Looking at the short shares, we see there were 3.58 Million shares sold at short interest cover period of 0 days.
The consensus price target for the stock as assigned by Wall Street analysts is $153.75, meaning bulls need an upside of 43.26% from its current market value. According to analyst projections, TWST’s forecast low is $100 with $200 as the target high. To hit the forecast high, the stock’s price needs a +86.36% upsurge from its current level, while the stock would need to tank -6.82% for it to hit the projected low.
Twist Bioscience Corporation (TWST) estimates and forecasts
Data shows that the Twist Bioscience Corporation share is not performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot +47.74% over the past 6 months, a 2% in annual growth rate that is considerably lower than the industry average of 7%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2021 revenue estimates. The rating firms predict current quarter revenue for Twist Bioscience Corporation will rise +9.4%, while the growth in revenue is estimated to hit -16.4% for the next quarter. Year-over-year growth is forecast to reach 31.7% up from the last financial year.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. The 2021 estimates are for Twist Bioscience Corporation earnings to increase by 8.9%, but the outlook for the next 5-year period is at 0% per year.
Twist Bioscience Corporation (NASDAQ:TWST)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 7.02% of Twist Bioscience Corporation shares while 88.84% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 95.55%. There are 285 institutions holding the Twist Bioscience Corporation stock share, with ARK Investment Management, LLC the top institutional holder. As of Dec 30, 2020, the company held 12.08% of the shares, roughly 5.88 Million TWST shares worth $830.36 Million.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 7.24% or 3.52 Million shares worth $497.82 Million as of Dec 30, 2020.
Among Mutual Funds, the top two as of Feb 27, 2021 were ARK ETF Tr-ARK Genomic Revolution ETF and ARK ETF Tr-ARK Innovation ETF. With 3328142 shares estimated at $458.09 Million under it, the former controlled 6.84% of total outstanding shares. On the other hand, ARK ETF Tr-ARK Innovation ETF held about 6.2% of the shares, roughly 3.01 Million shares worth around $414.89 Million.